Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.36B |
| Enterprise Value | 16.8B |
| P/E Ratio | -9.43 |
| PEG Ratio | -0.46 |
| Price/Sales Ratio | 9.96 |
| Price/Book Ratio | 10.69 |
| Enterprise/Revenue | 10.79 |
| Enterprise/EBITDA | -12.96 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.08 |
| Operating Margin | -0.97 |
AD
Management Effectiveness
| Return On Assets | -0.18 |
| Return On Equity | -1.8 |
Income Statement
| Revenue | 662.52M |
| Revenue/Share | 2.04 |
| Gross Profit | 662.52M |
| EBITDA | -737.97M |
| Net Income | -970.18M |
| Diluted EPS | -2.43 |
Balance Sheet
| Total Cash | 2.29B |
| Total Cash/Share | 5.35 |
| Total Debt | 2.95B |
| Total Debt/Equity | 3.38 |
| Current Ratio | 1.25 |
| Book Value Per Share | 2.46 |
Price History
| 52-Week Change | -51.2 |
| 52-Week High | 48.48 |
| 52-Week Low | 21.46 |
| Moving Average 50 Days | 27.2 |
| Moving Average 200 Days | 32.21 |
Statistics
| Average Volume | 8.41M |
| Shares Outstanding | 399.6M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.05 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
